TNF and neoplasm: In addition, miR-222, by targeting PTEN and tissue inhibitor of metalloproteinases-3 (TIMP3) tumor suppressors, induces tumor necrosis factor (TNF)-related apoptosis-inducing ligand resistance and enhances cellular migration through activation of the Akt pathway and metallopeptidases [28], [40].